The overall objective of this multi-center registry is to identify specific phenotypes of INOCA with both an anatomic evaluation (coronary angiography and intravascular imaging) and physiologic assessment with the Abbott Coroventis Coroflow Cardiovascular System, and to determine long-term outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The proportion of subjects with each physiologic phenotypes diagnosed with the Coroflow Cardiovascular System will be reported within 24-48 hours of the procedure.
Timeframe: up to 48 hours after the procedure
The proportion of subjects that experience Major Adverse Cardiovascular Events (MACE)
Timeframe: Up to 5 years
The proportion of subjects that exhibit mild, moderate or severe coronary artery stenosis
Timeframe: At the time of the procedure
Lesion length during the procedure
Timeframe: At the time of the procedure